Poses pregnancy risk and harm to children. How many unscrupulous doctors will prescribe this medication? Oh, I’m sure their will be plenty.
Given safety concerns, FDA scientists said Merck has agreed the drug will not be used in children.
Merck has ‘agreed’ to that? But has every doctor agreed to that? Every single doctor??? Do pay attention to how effective this drug really is.
Merck’s experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration.
On Friday morning Merck announced updated results from its molnupiravir study that showed a smaller benefit than first thought: Among more than 1,400 adults in a company study, the drug reduced the combined risk of hospitalization and death by 30 percent, less than the 50 percent first reported. Nearly 7 percent of patients who received Merck’s drug within five days of COVID-19 symptoms ended up in the hospital and one died. That compared to 10 percent of patients hospitalized who were taking a placebo and nine deaths.
Just take your Vitamin D, Zinc, C and Quercitin. That’s my opinion. And that’s what I do! Walking the talk. There are plenty of good studies showing the benefits of Vitamin D. And it won’t harm children or developing babies in the womb. Merck’s dangerous drug “appears” to have a smaller benefit then initially claimed with some big dangers. Which is why it was only authorized for “emergency use. Yup, another EUA. Undoubtedly the same will occur here in Canada.
- The FDA’s Antimicrobial Drugs Advisory Committee voted 13 to 10 to recommend emergency authorization of molnupiravir.
- Molnupiravir is an oral antiviral drug designed to treat adults with mild to moderate symptoms of Covid-19 who are at high risk of severe disease.
- Most committee members said it was a difficult vote, with unanswered questions about the drug’s safety and potential impact, however unlikely, on driving virus evolution.
- The drug needs final authorization from the FDA and CDC before it’s available to the public on an emergency basis.
I see more human guinea pigs
Potential risks were also identified in animal studies of molnupiravir, according to an analysis by FDA scientists, including possible embryo-fetal toxicity and birth defects. The agency’s report was posted in advance of a meeting Tuesday of the FDA’s outside experts who will weigh emergency use of the pill. Based on its findings, the FDA will ask its expert panel whether the pill should never be given during pregnancy or if it could be used in certain situations where the benefits outweigh the risks. Given the safety concerns, FDA scientists said Merck agreed the drug would not be used in children.